Patents by Inventor Petra Leyendecker

Petra Leyendecker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and device for the assessment of bowel function
    Patent number: 10258235
    Abstract: The present invention provides a method for assessing bowel function in a patient, comprising providing the patient with a numeric analog scale for at least one parameter which is a measure of bowel function; causing the patient to indicate on the numeric analog scale the amount and/or intensity of the parameter being experienced; and observing the amount and/or intensity of the at least one parameter indicated on the numeric analog scale in order to assess bowel function.
    Type: Grant
    Filed: February 28, 2006
    Date of Patent: April 16, 2019
    Assignee: Purdue Pharma L.P.
    Inventors: Petra Leyendecker, Michael Hopp, Axel Drews
  • METHODS OF TREATMENT COMPRISING ADMINISTERING A HIGH DAILY DOSE OF OXYCODONE AND NALOXONE IN A 2:1 WEIGHT RATIO
    Publication number: 20180104236
    Abstract: The present invention relates to methods of treatment comprising, inter alia, administering a high daily dose of oxycodone, such as a daily dose of at least 90 mg oxycodone, and naloxone in a 2:1 weight ratio to a patient in need thereof.
    Type: Application
    Filed: September 26, 2017
    Publication date: April 19, 2018
    Inventors: Michael HOPP, Petra Leyendecker, Wolfram Kremers
  • DOSAGE FORM CONTAINING OXYCODONE AND NALOXONE
    Publication number: 20180008593
    Abstract: The present invention concerns a dosage form comprising oxycodone and naloxone which is characterized by specific in vivo parameters such as tmax, Cmax, AUCt value, mean bowel function score and/or duration of analgesic efficacy.
    Type: Application
    Filed: March 23, 2017
    Publication date: January 11, 2018
    Inventors: Petra LEYENDECKER, Michael HOPP, Kevin SMITH
  • USE OF OPIOID ANTAGONISTS FOR TREATING URINARY RETENTION
    Publication number: 20140220146
    Abstract: The invention pertains to the use of opiod antagonists for the treatment of urinary retention.
    Type: Application
    Filed: April 10, 2014
    Publication date: August 7, 2014
    Applicant: Euro-Celtique S.A.
    Inventors: Michael HOPP, Petra LEYENDECKER
  • OPIOIDS FOR THE TREATMENT OF THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Publication number: 20140057933
    Abstract: The present invention relates to an opioid controlled release oral dosage form comprising at least one opioid for the manufacture of a medicament to treat patients with Chronic Obstructive Pulmonary Disease (COPD).
    Type: Application
    Filed: July 19, 2013
    Publication date: February 27, 2014
    Applicant: Euro-Celtique S.A.
    Inventors: Wolfgang FLEISCHER, Karen REIMER, Petra LEYENDECKER
  • DOSAGE FORM CONTAINING OXYCODONE AND NALOXONE
    Publication number: 20140031382
    Abstract: The present invention concerns a dosage form comprising oxycodone and naloxone which is characterized by specific in vivo parameters such as tmax, Cmax, AUCt value, mean bowel function score and/or duration of analgesic efficacy.
    Type: Application
    Filed: October 2, 2013
    Publication date: January 30, 2014
    Applicant: Euro-Celtique S.A.
    Inventors: Petra LEYENDECKER, Michael Hopp, Kevin Smith
  • Opioids for the treatment of the chronic obstructive pulmonary disease (COPD)
    Patent number: 8518925
    Abstract: The present invention relates to an opioid controlled release oral dosage form comprising at least one opioid for the manufacture of a medicament to treat patients with Chronic Obstructive Pulmonary Disease (COPD).
    Type: Grant
    Filed: June 8, 2005
    Date of Patent: August 27, 2013
    Assignee: Euro-Celtique S.A.
    Inventors: Wolfgang Fleischer, Karen Reimer, Petra Leyendecker
  • DOSAGE FORM CONTAINING OXYCODONE AND NALOXONE
    Publication number: 20120225901
    Abstract: The present invention concerns a dosage form comprising oxycodone and naloxone which is characterized by specific in vivo parameters such as tmax, Cmax, AUCt value, mean bowel function score and/or duration of analgesic efficacy.
    Type: Application
    Filed: December 16, 2011
    Publication date: September 6, 2012
    Applicant: Euro-Celtique S.A.
    Inventors: Petra LEYENDECKER, Michael Hopp, Kevin Smith
  • USE OF OPIOID ANTAGONISTS FOR TREATING URINARY RETENTION
    Publication number: 20110177133
    Abstract: The invention pertains to the use of opioid antagonists for the treatment of urinary retention.
    Type: Application
    Filed: July 7, 2009
    Publication date: July 21, 2011
    Inventors: Michael Hopp, Petra Leyendecker
  • DOSAGE FORM CONTAINING OXYCODONE AND NALOXONE
    Publication number: 20110172259
    Abstract: The present invention concerns a dosage form comprising oxycodone and naloxone which is characterized by specific in vivo parameters such as tmax, Cmax, AUCt value, mean bowel function score and/or duration of analgesic efficacy.
    Type: Application
    Filed: November 12, 2010
    Publication date: July 14, 2011
    Inventors: Petra Leyendecker, Michael Hopp, Kevin Smith
  • Method and Device for the Assessment of Bowel Function
    Publication number: 20080167533
    Abstract: The present invention provides a method for assessing bowel function in a patient, comprising providing the patient with a numeric analog scale for at least one parameter which is a measure of bowel function; causing the patient to indicate on the numeric analog scale the amount and/or intensity of the parameter being experienced; and observing the amount and/or intensity of the at least one parameter indicated on the numeric analog scale in order to assess bowel function.
    Type: Application
    Filed: February 28, 2006
    Publication date: July 10, 2008
    Inventors: Petra Leyendecker, Michael Hopp, Axel Drews
  • Dosage Form Containing Oxycodone and Naloxone
    Publication number: 20080145429
    Abstract: The present invention concerns a dosage form comprising oxycodone and naloxone which is characterized by specific in vivo parameters such as tmax, Cmax, AUCt value, mean bowel function score and/or duration of analgesic efficacy.
    Type: Application
    Filed: February 28, 2006
    Publication date: June 19, 2008
    Inventors: Petra Leyendecker, Michael Hopp, Kevin Smith
  • Opioids for the treatment of the chronic obstructive pulmonary disease (copd)
    Publication number: 20070185146
    Abstract: The present invention relates to an opioid controlled release oral dosage form comprising at least one opioid for the manufacture of a medicament to treat patients with Chronic Obstructive Pulmonary Disease (COPD).
    Type: Application
    Filed: June 8, 2005
    Publication date: August 9, 2007
    Applicant: Euro-Celtique S.A.
    Inventors: Wolfgang Fleischer, Karen Reimer, Petra Leyendecker